| 75.76 Delayed Data As of Aug 23 |  -1.64 / -2.12%Today’s Change | 71.53 Today|||52-Week Range 106.74 | -11.03% Year-to-Date |
| Previous close | 77.40 |
| Today’s open | 77.28 |
| Day’s range | 75.49 - 77.47 |
| Volume | 1,218,181 |
| Average volume (3 months) | 1,331,913 |
| Market cap | $13.6B |
| Earnings growth (last year) | +34.91% |
| Earnings growth (this year) | -8.61% |
| Earnings growth (next 5 years) | +52.80% |
| Revenue growth (last year) | +13.51% |
| P/E ratio | NM |
| Price/Sales | 10.07 |
| Price/Book | 4.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXASExact Sciences Corp | -0.91 | -0.77% |
| NBIXNeurocrine Bioscienc... | +0.35 | +0.36% |
| TECHBio-Techne Corp | -3.81 | -1.99% |
| BLUEbluebird bio Inc | -2.98 | -2.72% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | -$77.2M |
| Net profit margin | -5.16% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Jean-Jacques Bienaimé |
Chief Financial Officer & Executive Vice President Dan Spiegelman |
Corporate headquarters San Rafael, California |
